Subscribe
ca-ssis
ca-ssis / iStockphoto.com
11 October 2018Americas

FDA issues guidance on generic versions of complex drugs

The US Food and Drug Administration (FDA) has released guidance intended to advance the development of generic versions of complex medical drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.

More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Biotechnology
FDA releases plan to boost biosimilars development
13 December 2018   The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.
Medtech
FDA unveils plans to boost innovation of medical devices
19 December 2018   The US Food and Drug Administration has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool